 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 07/29/2020 |
$1.13 |
$1.51 |
$1.13 |
$1.45 |
48.81M | | 07/30/2020 |
$1.32 |
$1.41 |
$1.20 |
$1.23 |
11.69M | | 07/31/2020 |
$1.19 |
$1.27 |
$1.15 |
$1.18 |
4.86M | | 08/03/2020 |
$1.22 |
$1.31 |
$1.18 |
$1.26 |
7.15M | | 08/04/2020 |
$1.25 |
$1.30 |
$1.17 |
$1.27 |
2.95M |
|
|
| Adamis Pharmaceuticals is a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including respiratory disease, allergy and opioid overdose. Co.'s products and product candidates include: Symjepi™ (epinephrine) Injection 0.3mg for use in the emergency treatment of acute allergic reactions, including anaphylaxis; Symjepi™ (epinephrine) Injection 0.15mg for use in the treatment of anaphylaxis for patients weighing 33 to 66 pounds; a naloxone injection product candidate ZIMHI™ for the treatment of opioid overdose; a Beclomethasone metered dose inhaler product candidate (APC-1000) for the treatment of asthma; and among others. |
|
|
Adamis Pharmaceuticals (ADMP) has the following price history information. Looking back at ADMP historical stock prices for the last five trading days, on July 29, 2020, ADMP opened at $1.13, traded as high as $1.51 and as low as $1.13, and closed at $1.45. Trading volume was a total of 48.81M shares. On July 30, 2020, ADMP opened at $1.32, traded as high as $1.41 and as low as $1.20, and closed at $1.23. Trading volume was a total of 11.69M shares. On July 31, 2020, ADMP opened at $1.19, traded as high as $1.27 and as low as $1.15, and closed at $1.18. Trading volume was a total of 4.86M shares. On August 03, 2020, ADMP opened at $1.22, traded as high as $1.31 and as low as $1.18, and closed at $1.26. Trading volume was a total of 7.15M shares. On August 04, 2020, ADMP opened at $1.25, traded as high as $1.30 and as low as $1.17, and closed at $1.27. Trading volume was a total of 2.95M shares.
ADMP Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Adamis Pharmaceuticals shares, starting with a $10,000 purchase of ADMP, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
08/05/2010 |
|
| End date: |
08/04/2020 |
|
| Start price/share: |
$4.59 |
|
| End price/share: |
$1.27 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-72.33% |
|
| Average Annual Total Return: |
-12.05% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$2,767.28 |
|
| Years: |
10.01 |
|
|
|
| Date |
Close |
| 07/29/2020 | $1.45 | | 07/30/2020 | $1.23 | | 07/31/2020 | $1.18 | | 08/03/2020 | $1.26 | | 08/04/2020 | $1.27 |
|
|
